Prenatal substance exposure, defined as the exposure of a fetus to alcohol or drugs during pregnancy, can impact a range of infant health outcomes and lead to long-term negative effects on child development. This report summarizes recent trends in prenatal substance exposure among infants in Washington’s Medicaid program (Apple Health); in maternal substance use during pregnancy; and in access to treatment during pregnancy and postpartum. Opportunities to supplement treatment with additional supports are also discussed.
Report and/or Additional Information:
Categories:
Related Publications:
- 2003 County Profile of Substance Use and Need for Treatment Services (4.52)
- About the King County ICM Pilot Participants (4.63)
- About the Thurston/Mason ICM Pilot Participants (4.62)
- Alcohol and Substance Use among Adolescents in Foster Care in Washington State (4.38)
- Alcohol and Substance Use Among Adolescents in Washington State (4.35)
- Behavioral Health Treatment Needs and Outcomes for Washington Counties (4.95)
- Bringing Recovery into Diverse Groups through Engagement and Support (4.93)
- Characteristics of People with Apple Health and Stimulant Use Disorder Diagnosis in Washington State: Prevalence, Geographic Distribution and Healthcare Service Utilization over Five Years (Fiscal Years 2018 to 2022) (11.279)
- Geographic Distribution of Patients in Washington State’s Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project (9.114)
- Identifying Substance Use and Mental Health Disorders Using an SBIRT Model: Washington State's Experience (11.242)
- Intensive Case Management as a Community-Based Stand-Alone Service (4.71)
- Intensive Case Management within a Supportive Housing Facility (4.70)
- Overdose Deaths among Medicaid Enrollees in Washington State (4.92)
- Profile of Substance Use and Need for Treatment Services in Washington State (4.32)
- Substance Use, Substance Use Disorders, and Need for Treatment among Washington State Adults (4.25)
- Sustainability of Screening, Brief Intervention, and Referral to Treatment in Healthcare Settings (4.101)
- Washington State Healthy Transitions Project: Findings from the Impact Evaluation (3.58)
- Washington State Jail-based Opioid Treatment Networks: Disparities in Initiation of MOUD Treatment (4.115)
- Washington State Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project: Year One Performance (4.96)
- Washington State SBIRT Primary Care Integration: Implementation (4.98)
- Washington State Youth Treatment Implementation (WSYT-I) Program: Final Evaluation Report (4.103)
- Washington State’s Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project – Preliminary Outcomes through Year Two (4.102)